<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10081673</article-id><article-id pub-id-type="pmc">2627691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ramos</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tanuri</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schechter</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rayfield</surname><given-names>M. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>D. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cabral</surname><given-names>M. C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bandea</surname><given-names>C. I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Baggs</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pieniazek</surname><given-names>D.</given-names></name></contrib></contrib-group><aff>Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</aff><pub-date pub-type="ppub"><season>Jan-Feb</season><year>1999</year></pub-date><volume>5</volume><issue>1</issue><fpage>65</fpage><lpage>74</lpage><abstract><p>We systematically evaluated multiple and recombinant infections in an HIV-infected population selected for vaccine trials. Seventy-nine HIV-1 infected persons in a clinical cohort study in Rio de Janeiro, Brazil, were evaluated for 1 year. A combination of molecular screening assays and DNA sequencing showed 3 dual infections (3.8%), 6 recombinant infections (7.6%), and 70 (88.6%) infections involving single viral subtypes. In the three dual infections, we identified HIV-1 subtypes F and B, F and D, and B and D; in contrast, the single and recombinant infections involved only HIV-1 subtypes B and F. The recombinants had five distinct B/F mosaic patterns: Bgag-p17/Bgag-p24/Fpol/Benv, Fgag-p17/Bgag-p24/Fpol/Fenv, Bgag-p17/B-Fgag-p24/Fpol/Fenv, Bgag-p17/B-Fgag-p24/Fpol/Benv, and Fgag-p17/B-Fgag-p24/Fpol/Fenv. No association was found between dual or recombinant infections and demographic or clinical variables. These findings indicate that dual and recombinant infections are emerging as an integral part of the HIV/AIDS epidemic in Brazil and emphasize the heterogenous character of epidemics emerging in countries where multiple viral subtypes coexist.</p></abstract></article-meta></front></article>

